CME Group (NASDAQ:CME) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $264.00 to $266.00. They now have a "sell" rating on the stock.
S&P 500 Bulls Rattled By Cost To Build Out AI [Seeking Alpha]
CME Group's Strength Is Clear, But The Stock Looks Fully Valued [Seeking Alpha]
CME Group (NASDAQ:CME) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $312.00 to $316.00. They now have a "buy" rating on the stock.
CME Group (NASDAQ:CME) had its "neutral" rating reaffirmed by analysts at UBS Group AG.